Literature DB >> 31076382

Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol.

Hilary A Robbins1, Matthew Callister2, Peter Sasieni3, Samantha L Quaife4, Li C Cheung5, Paul Brennan6, Hormuzd A Katki5, Christine D Berg5, David Baldwin7, Mattias Johansson6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31076382      PMCID： PMC6992839          DOI： 10.1016/S2213-2600(19)30136-5

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  8 in total

1.  Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.

Authors:  Paul F Pinsky; David S Gierada; William Black; Reginald Munden; Hrudaya Nath; Denise Aberle; Ella Kazerooni
Journal:  Ann Intern Med       Date:  2015-04-07       Impact factor: 25.391

2.  British Thoracic Society guidelines for the investigation and management of pulmonary nodules.

Authors:  M E J Callister; D R Baldwin; A R Akram; S Barnard; P Cane; J Draffan; K Franks; F Gleeson; R Graham; P Malhotra; M Prokop; K Rodger; M Subesinghe; D Waller; I Woolhouse
Journal:  Thorax       Date:  2015-08       Impact factor: 9.139

Review 3.  European position statement on lung cancer screening.

Authors:  Matthijs Oudkerk; Anand Devaraj; Rozemarijn Vliegenthart; Thomas Henzler; Helmut Prosch; Claus P Heussel; Gorka Bastarrika; Nicola Sverzellati; Mario Mascalchi; Stefan Delorme; David R Baldwin; Matthew E Callister; Nikolaus Becker; Marjolein A Heuvelmans; Witold Rzyman; Maurizio V Infante; Ugo Pastorino; Jesper H Pedersen; Eugenio Paci; Stephen W Duffy; Harry de Koning; John K Field
Journal:  Lancet Oncol       Date:  2017-12       Impact factor: 41.316

4.  Low-dose CT for lung cancer screening.

Authors:  Alberto Ruano-Ravina; Mónica Pérez-Ríos; Pere Casàn-Clará; Mariano Provencio-Pulla
Journal:  Lancet Oncol       Date:  2018-03       Impact factor: 41.316

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Overdiagnosis in low-dose computed tomography screening for lung cancer.

Authors:  Edward F Patz; Paul Pinsky; Constantine Gatsonis; Jorean D Sicks; Barnett S Kramer; Martin C Tammemägi; Caroline Chiles; William C Black; Denise R Aberle
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

7.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

8.  Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.

Authors:  U Pastorino; M Silva; S Sestini; F Sabia; M Boeri; A Cantarutti; N Sverzellati; G Sozzi; G Corrao; A Marchianò
Journal:  Ann Oncol       Date:  2019-10-01       Impact factor: 32.976
  8 in total
  6 in total

1.  Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action.

Authors:  Chyke A Doubeni; John M Wilkinson; Neil Korsen; David E Midthun
Journal:  Ann Fam Med       Date:  2020-05       Impact factor: 5.166

2.  The Role of Programmed Cell Death Receptor 1 in Lung Cancer.

Authors:  Dumitru Cristinel Badiu; Anca Zgura; Claudia Mehedintu; Bogdan Haineala; Rodica Anghel; Xenia Bacinschi
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

Review 3.  Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.

Authors:  Asha Bonney; Reem Malouf; Corynne Marchal; David Manners; Kwun M Fong; Henry M Marshall; Louis B Irving; Renée Manser
Journal:  Cochrane Database Syst Rev       Date:  2022-08-03

4.  What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?

Authors:  Stephen H Bradley; Bethany Shinkins; Martyn Pt Kennedy
Journal:  J R Soc Med       Date:  2021-03-10       Impact factor: 5.344

5.  A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil.

Authors:  Adalberto Miranda-Filho; Hadrien Charvat; Freddie Bray; Arn Migowski; Li C Cheung; Salvatore Vaccarella; Mattias Johansson; Andre L Carvalho; Hilary A Robbins
Journal:  EClinicalMedicine       Date:  2021-11-01

6.  Low-dose CT for lung cancer screening: position paper from the Italian college of thoracic radiology.

Authors:  Mario Silva; Giulia Picozzi; Nicola Sverzellati; Sandra Anglesio; Maurizio Bartolucci; Edoardo Cavigli; Annalisa Deliperi; Massimo Falchini; Fabio Falaschi; Domenico Ghio; Paola Gollini; Anna Rita Larici; Alfonso V Marchianò; Stefano Palmucci; Lorenzo Preda; Chiara Romei; Carlo Tessa; Cristiano Rampinelli; Mario Mascalchi
Journal:  Radiol Med       Date:  2022-03-20       Impact factor: 6.313
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.